Patent Assignment
Reel/Frame 051421/0868
Assignment of Assignor's Interest
Recorded: 2020-01-06
Pages: 10
Assignors
SIDDIQUI-JAIN, ADAM
Executed: 2019-12-18
FLYNN, PAUL
Executed: 2019-12-10
FUJIWARA, YUJI
Executed: 2019-12-18
Assignee
TOLERO PHARMACEUTICALS, INC.
3900 N. TRAVERSE MOUNTAIN BLVD., LEHI, UTAH, 84043
Covered Property
(1)
CDK9 Inhibitors and Polymorphs Thereof for Use as Agents for Treatment of Cancer
Patent:
11,034,710 →
Application:
16/703,773 →
Publication:
US 2020/0255462
PCT:
PCT/US2019/064549 ↗
Related Assignments
(5)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 6, 2020
From: MASUMOTO, SHUJI; TANAKA, HIROAKI; KUREBAYASHI, HIROTAKA; HASHIZUKA, TAKAHIKO
To: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
Reel/Frame 051422/0194 →
Assignment of Assignor's Interest
Jan 6, 2020
From: SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED
To: TOLERO PHARMACEUTICALS, INC.
Reel/Frame 051422/0287 →
Merger
Jul 10, 2020
From: TOLERO PHARMACEUTICALS, INC.
To: BOSTON BIOMEDICAL, INC.
Reel/Frame 053172/0833 →
Change of Name
Jul 10, 2020
From: BOSTON BIOMEDICAL, INC.
To: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
Reel/Frame 053184/0705 →
Change of Name
Apr 27, 2022
From: SUMITOMO DAINIPPON PHARMA ONCOLOGY, INC.
To: SUMITOMO PHARMA ONCOLOGY, INC.
Reel/Frame 059809/0557 →